FindTrial
Sign In

Correlation between Natural Antibody and Rejection after Renal Transplantation

Correlation between Natural Antibody and Rejection after Renal Transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020436
Enrollment
Unknown
Registered
2018-12-29
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal transplantation

Interventions

Case series:Nil

Sponsors

Tianjin the first central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Retrospective study of 200 patients with renal transplantation from 2016 to 2018 2. Adult male or female 3. All donors and recipients have the same ABO blood type 4. Preoperative complement-dependent lymphocyte toxicity test is negative 5. Postoperative use of cyclosporine A (tacrolimus) + morphine mycolipid + prednisone triple immunosuppressive regimen)

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

MeasureTime frame
Natural antibodies;—

Countries

China

Contacts

Public ContactLiu Wei

Tianjin the first central Hospital

liuwei2024@126.com+86 13502189965

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026